Cart
sales@molnova.com
1-Naphthyl PP1
CAS No. 221243-82-9
1-Naphthyl PP1( 1-NA-PP 1 )
Catalog No. M22268 CAS No. 221243-82-9
1-Naphthyl PP1 is a selective src inhibitor(v-Src and c-Fyn, c-Abl, CDK2 and CAMK II with IC50s of 1.0, 0.6, 0.6, 18 and 22 μM, respectively)
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 75 | In Stock |
|
| 2MG | 33 | In Stock |
|
| 5MG | 68 | In Stock |
|
| 10MG | 93 | In Stock |
|
| 25MG | 198 | In Stock |
|
| 50MG | 314 | In Stock |
|
| 100MG | 508 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name1-Naphthyl PP1
-
NoteResearch use only, not for human use.
-
Brief Description1-Naphthyl PP1 is a selective src inhibitor(v-Src and c-Fyn, c-Abl, CDK2 and CAMK II with IC50s of 1.0, 0.6, 0.6, 18 and 22 μM, respectively)
-
Description1-Naphthyl PP1 is a selective src inhibitor(v-Src and c-Fyn, c-Abl, CDK2 and CAMK II with IC50s of 1.0, 0.6, 0.6, 18 and 22 μM, respectively)
-
In Vitro——
-
In Vivo——
-
Synonyms1-NA-PP 1
-
PathwayTyrosine Kinase
-
TargetSrc
-
RecptorSrc
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number221243-82-9
-
Formula Weight317.39
-
Molecular FormulaC19H19N5
-
Purity>98% (HPLC)
-
SolubilityDMSO:12 mg/mL (37.8 mM; Need ultrasonic)
-
SMILESCC(N1N=C(C2=C3C=CC=CC3=CC=C2)C4=C(N)N=CN=C41)(C)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Tandon M, et al. New pyrazolopyrimidine inhibitors of protein kinase d as potent anticancer agents for prostate cancer cells. PLoS One. 2013 Sep 23;8(9):e75601.
molnova catalog
related products
-
SB273005
SB273005 is a potent integrin inhibitor with Ki of 1.2 nM and 0.3 nM for αvβ3 receptor and αvβ5 receptor, respectively.
-
Tirbanibulin Mesylat...
Tirbanibulin Mesylate is an inhibitor of Src that targets the peptide substrate site of Src.
-
Pulegone
Pulegone has cytotoxicity followed by regenerative cell proliferation is the MOA for Pulegone-induced urothelial tumors in female rats.
